Keys to IGEA's success

The "discovery" made by IGEA

IGEA was the first company to have understood that physical stimuli can be used to modify and regulate the biological activities and that the effects can be used for clinical treatment. IGEA has shown that the effectiveness of the physical stimuli depends on the parameters that characterize them: frequency, amplitude, signal shape.  Therapeutic efficacy and specificity of the signals are closely related in an innovative therapeutic approach that is realized in Clinical Biophysics.

 

International Acitivities

IGEA has established two foreign registered offices:

United Kngdom: 16 Old Bailey - London EC4M 7AG

Germany: AM Moosfeld, 98 81829 Munchen

 

Consultants for company expansion: 

Europe: Luciano Cattani, member of the board of directors 

USA: Jackie Eastwood 

 

Financial resources have been obtained through two capital increases in 2008 and 2010 with:

Atlantes Ventures

Innogest